BYOD in Clinical Trials: When, Why, and How?

Uncover the potential of Bring Your Own Device (BYOD) strategies for decentralized clinical trials.

The digital transformation of clinical trials, accelerated by COVID-19, has positioned BYOD as a powerful approach for collecting patient data electronically. But what makes BYOD such a game-changer, and how can it be implemented successfully?

In this white paper, you’ll discover:
🔹 Key characteristics that make BYOD a strong feature for decentralized trials
🔹 The technical options and advantages for both patients and sponsors
🔹 Challenges such as regulatory uncertainty, technical limits, and data privacy risks

Despite its promise, few studies have adopted BYOD, reflecting the complexity of implementation. By exploring both its value and limits, stakeholders can unlock its potential and contribute to the future of clinical trial digitalization.

👉 Download the white paper and start your BYOD journey today!